It said "Big Pharma is diversifying geographically, benefiting Indian CRDMOs with small molecule expertise". The report highlighted some major pharma companies (Including Piramal Pharma, Syngene, ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

Boston and London biotech company Vertex Pharmaceuticals is on a roll ... based treatment for type 1 diabetes that could potentially help people skip regular insulin injections by giving them healthy ...